RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanomaFlorence Laugier, Nicolas Dumaz|Oncotarget|2015Cited by 33
RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted TherapyAhlem Jebali, Nicolas Dumaz|Biomedicines|2021Cited by 15
FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated MelanomaPauline Tétu, Nicolas Dumaz|Cancers|2020Cited by 9
PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitorsJulie Delyon, Nicolas Dumaz|Cell Communication and Signaling|2024Cited by 4